Source: Eur Respir J, 54 (2) 1901459; 10.1183/13993003.01459-2019
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Kristina Laubhahn, Bianca Schaub. Paediatric severe asthma: a need for novel innate molecular phenotypes. Eur Respir J, 54 (2) 1901459; 10.1183/13993003.01459-2019

Member's Comments

No comment yet.

Related content which might interest you: Paediatric respiratory epidemiology: asthma phenotypes – do they exist? Source: Annual Congress 2009 - Paediatric year in review Year: 2009 Identification of therapeutic targets for steroid-insensitive asthma using models that represent different clinical subtypes of disease Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding Year: 2016 Identification of molecular pathways in distinct asthma phenotypes identified in ADEPT Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015 Identification of novel pathogenic mechanisms triggered by arginase activation in patients with COPD Source: International Congress 2016 – Airway response to infection Year: 2016 Pulmonary type-2 innate lymphoid cells in paediatric severe asthma: phenotype and response to steroids Source: Eur Respir J, 54 (2) 1801809; 10.1183/13993003.01809-2018 Year: 2019 New phenotyping of corticosteroid-resistant asthma based on molecular mechanisms Source: Annual Congress 2005 - Genetic polymorphisms and molecular mechanisms in asthma pathophysiology Year: 2005 A novel evaluation of the impact of severe allergic asthma in children: The family perspective Source: Annual Congress 2010 - Quality of life, asthma control and monitoring childhood asthma Year: 2010 Integrating fingerprints: molecular phenotyping of severe asthma Source: International Congress 2015 – Fingerprinting severe asthma Year: 2015 PTX3 a marker of innate immune responses in the airways of asthmatics and COPD patients Source: Annual Congress 2013 –Asthma: new mechanisms and markers Year: 2013 LATE-BREAKING ABSTRACT: Associations and interactions of genetic polymorphisms in innate immunity genes with early viral infections and susceptibility to asthma and asthma-related phenotypes Source: Annual Congress 2012 - Gene-environment treatment and asthma Year: 2012 Translational research approaches for finding new therapeutic targets involved in viral-induced asthma and COPD exacerbation Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014 Care pathways for the selection of a biologic in severe asthma Source: Eur Respir J, 50 (6) 1701782; 10.1183/13993003.01782-2017 Year: 2017 Defining asthma phenotypes Source: Annual Congress 2013 –MS4 Asthma phenotypes and endotypes Year: 2013 Assessment of innate immunity mediators in the lung of COPD patients: relation with disease manifestations Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity Year: 2020 The role of infections in the induction of asthma: genetic and inflammatory drivers Source: Annual Congress 2007 - PG24 - GRACE full-day course. From cough to asthma: the role of infection Year: 2007 Occupational asthma: classical and novel causes and diagnostic approaches Source: International Congress 2019 – PG13 Traditional and modern clinical approaches for diagnosis and management of occupational airways diseases Year: 2019 Different innate neutrophil responses in controlled and uncontrolled asthma Source: International Congress 2015 – Advances from translational research in respiratory infections Year: 2015 Mechanisms of COPD exacerbations - molecular perspectives and pathophysiology Source: ERS Satellites 2021 Year: 2021 Aetiology of exacerbations of asthma and COPD: new viruses, new mechanisms Source: Annual Congress 2010 - Severe exacerbations in asthma and COPD: new causes, mechanisms and models of care Year: 2010